Janet S Lee Selected Research

Janet S Lee Research Topics

Disease

22	Inflammation (Inflammations) 11/2021 - 02/2003
15	Pneumonia (Pneumonitis) 06/2022 - 02/2003
11	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 04/2007
9	COVID-19 06/2022 - 01/2020
8	Lung Injury 01/2021 - 12/2003
8	Infections 01/2021 - 12/2016
6	Wounds and Injuries (Trauma) 07/2022 - 04/2012
6	Emphysema 09/2012 - 10/2008
5	Critical Illness (Critically Ill) 05/2022 - 11/2013
5	Sepsis (Septicemia) 03/2022 - 12/2003
5	Neoplasms (Cancer) 01/2021 - 07/2002
5	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021 - 01/2017
5	Rheumatoid Arthritis 02/2016 - 07/2011
4	Hemolysis 01/2020 - 07/2011
3	Lung Diseases (Lung Disease) 01/2021 - 10/2008
2	Respiratory Sounds (Crackle) 06/2022 - 01/2020
2	Cystic Fibrosis (Mucoviscidosis) 01/2021 - 01/2017
2	Anemia 06/2014 - 03/2012
2	Acute Lung Injury 12/2003 - 02/2003
1	Hemorrhage 06/2022
1	Lymphopenia (Lymphocytopenia) 03/2022
1	Viremia 01/2022
1	Death (Near-Death Experience) 10/2021
1	Reperfusion Injury 10/2021
1	Dermatitis 01/2021
1	Noncommunicable Diseases 01/2021
1	Asthma (Bronchial Asthma) 01/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Skin Diseases (Skin Disease) 01/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021
1	Pseudomonas Infections 01/2021
1	Glucosephosphate Dehydrogenase Deficiency 01/2020
1	Edema (Dropsy) 01/2020
1	Malaria 01/2020
1	Hemolytic Anemia 01/2020
1	Acute Kidney Injury (Acute Renal Failure) 12/2019

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 06/2022 - 03/2006
8	Interleukin-6 (Interleukin 6)IBA 06/2022 - 03/2011
7	Biomarkers (Surrogate Marker)IBA 06/2022 - 08/2009
7	CytokinesIBA 01/2021 - 12/2003
6	SmokeIBA 09/2012 - 04/2007
5	tocilizumab (atlizumab)FDA Link 02/2016 - 07/2011
5	ChemokinesIBA 07/2010 - 05/2003
4	RNA (Ribonucleic Acid)IBA 06/2022 - 01/2020
3	LipidsIBA 01/2017 - 02/2015
3	IronIBA 01/2017 - 01/2013
3	Bronchodilator Agents (Bronchodilators)IBA 09/2015 - 06/2014
3	SteroidsIBA 09/2015 - 06/2014
2	AntibodiesIBA 06/2022 - 01/2022
2	Oxygen (Dioxygen)IBA 06/2022 - 06/2014
2	Type I Tumor Necrosis Factor ReceptorsIBA 06/2022 - 01/2018
2	Viral RNAIBA 05/2022 - 01/2022
2	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 03/2022 - 01/2021
2	AntigensIBA 01/2022 - 02/2003
2	Pancreatic Elastase (Elastase)IBA 11/2021 - 01/2021
2	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 01/2018
2	Thrombospondin 1IBA 01/2021 - 01/2018
2	Complement System Proteins (Complement)IBA 01/2021 - 01/2020
2	Virulence Factors (Pathogenicity Factors)IBA 12/2019 - 01/2018
2	Type II Secretion SystemsIBA 12/2019 - 01/2018
2	Cardiolipins (Cardiolipin)IBA 11/2017 - 09/2015
2	Interleukin-10 (Interleukin 10)IBA 11/2017 - 08/2011
2	Biological ProductsIBA 01/2017 - 11/2013
2	LipopolysaccharidesIBA 12/2016 - 04/2013
2	Lipoproteins (Lipoprotein)IBA 02/2016 - 04/2015
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 04/2015 - 07/2011
2	Calcium-Calmodulin-Dependent Protein KinasesIBA 11/2013 - 08/2011
1	AnticoagulantsIBA 07/2022
1	Indicators and Reagents (Reagents)IBA 07/2022
1	Tissue Plasminogen Activator (Alteplase)FDA Link 06/2022
1	Antiviral Agents (Antivirals)IBA 06/2022
1	EnzymesIBA 03/2022
1	Histones (Histone)IBA 03/2022
1	InterferonsIBA 12/2021
1	coactivator-associated arginine methyltransferase 1IBA 01/2021
1	Heme Oxygenase-1IBA 01/2021
1	N 30IBA 01/2021
1	ChromatinIBA 01/2021
1	Heme (Haem)IBA 01/2021
1	Interleukin-1 (Interleukin 1)IBA 01/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2021
1	Cholinergic Agents (Cholinergics)IBA 01/2020
1	glucose-6-phosphate dehydrogenase A-IBA 01/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2020
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 01/2020
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2019
1	Apyrase (ATP Diphosphatase)IBA 12/2019
1	Thrombopoietin ReceptorsIBA 12/2019
1	Type III Secretion SystemsIBA 12/2019

Therapy/Procedure

7	Therapeutics 05/2022 - 07/2002
5	Artificial Respiration (Mechanical Ventilation) 06/2022 - 12/2019
3	Nebulizers and Vaporizers (Inhaler) 09/2015 - 06/2014
2	Ligation 10/2021 - 11/2013
2	Erythrocyte Transfusion 04/2012 - 03/2012
1	Extracorporeal Membrane Oxygenation 06/2022
1	Noninvasive Ventilation 06/2022
1	Terminal Care (Care, Terminal) 01/2022
1	Warm Ischemia 10/2021
1	Subacute Care 01/2021